Sizi Chen

As the leading global authority on the evolution of digital health technology, Digital Therapeutics Alliance (DTA) is a 501(c)(6) non-profit trade association of industry leaders and stakeholders dedicated to the understanding, adoption, and integration of digital therapeutics into healthcare. DTA works to enable expanded access to high quality, evidence-based digital therapeutics for patients, clinicians, and payors to improve clinical and health economic outcomes. As the leading international organization on digital therapeutic thought leadership and education, DTA provides the digital health ecosystem with the necessary tools to define, evaluate, and utilize DTx products. For more information, please visit: www.dtxalliance.org.

As the leading global authority on the evolution of digital health technology, Digital Therapeutics Alliance (DTA) is a 501(c)(6) non-profit trade association of industry leaders and stakeholders dedicated to the understanding, adoption, and integration of digital therapeutics into healthcare. DTA works to enable expanded access to high quality, evidence-based digital therapeutics for patients, clinicians, and payors to improve clinical and health economic outcomes. As the leading international organization on digital therapeutic thought leadership and education, DTA provides the digital health ecosystem with the necessary tools to define, evaluate, and utilize DTx products. For more information, please visit: www.dtxalliance.org.

FoundersX is an early-stage venture capital firm based in Silicon Valley with our East Coast office located at Harvard Square, Cambridge, MA. Established in 2016, we are a deep-domain winner, investing in the next wave of unicorns building GenAI infrastructure and unlocking values in enterprise SaaS, Fintech, digital health and techbio. Our investment team is mostly from Stanford & Harvard. We are winning the Power Law with deep-dive research capacity and top-notch deal flow. We are strongly positioned to write the 1st VC checks to top 1% GenAI startups as seed round lead investors. We can co-lead A round companies and highly selectively lead B rounds of our high growth portfolio companies through our opportunity funds. We are backed by institutional investors, featured on the WSJ and Business Insider as a pioneering tech VC.